Counteraction of interferon-induced antiviral responses by herpes simplex viruses

Current Topics in Microbiology and Immunology

Volumn 269, Issue , 2002, Pages 171-185

  Leib, D A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PROTEIN KINASE; RIBONUCLEASE; PPPA(2'P5'A)N DEPENDENT RIBONUCLEASE; PPPA(2'P5'A)N-DEPENDENT RIBONUCLEASE; PROTEIN KINASE R;

ARTICLE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HOST RESISTANCE; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS INHIBITION; VIRUS RESISTANCE; VIRUS VIRULENCE; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PHYSIOLOGY; REVIEW; VIRUS REPLICATION;

SIMPLEXVIRUS;

ANIMALS; EIF-2 KINASE; ENDORIBONUCLEASES; GENES, VIRAL; HERPES SIMPLEX; HUMANS; IMMUNITY, NATURAL; INTERFERONS; SIMPLEXVIRUS; VIRUS REPLICATION;

EID: 0035988036     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-59421-2_11     Document Type: Article

References (81)

1. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors
2. Mx transgenic mice - Animal models of health
3. Mechanism of interferon action. The interferon-induced phosphoprotein P1 possesses a double-stranded RNA-dependent ATP-binding site
4. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures
5. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2
6. The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha
7. Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase
8. Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5-mutants of herpes simplex virus 1
9. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture
10. The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+
11. Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage
12. Transcription factors in interferon signaling
13. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis
14. Herpes simplex virus Us11 protein enhances recovery of protein synthesis and survival in heat shock treated HeLa cells
15. Status of the 1CP34.5 gene in herpes simplex virus type 1 strain 17
16. 2-5A-dependent RNase molecules dimerize during activation by 2-5A
17. The herpes simplex virus 1 US11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production
18. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein
19. A viral activator of gene expression functions via the ubiquitin-proteasome pathway
20. Mutational analysis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): Characterization of HSV type 1 (HSV-1)/HSV-2 chimeras
21. Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1
22. Transfer of UL41, the gene controlling virion-associated host cell shutoff, between different strains of herpes simplex virus
23. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures
24. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34,5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells
25. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase
26. Mammalian GADD34, an apoptosis- and DNA damage-inducible gene
27. Virus interference. I. The interferon
28. The product of gene US11 of herpes simplex virus type 1 is expressed as a true late gene
29. pppA2′p5′A2′p5′A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells
30. Effect of deficiency of the double-stranded RNA-dependent protein kinase. PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes
31. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κ B by phosphorylating I kappa B
32. The herpes simplex virus virion host shutoff function
33. Evidence endogenous interferon production contributed to the lack of ocular virulence of an HSV intertypic recombinant
34. Interferon, double-stranded RNA, and protein phosphorylation
35. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency
36. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo
37. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
38. The products of gene US11 of herpes simplex virus type 1 are DNA-binding and localize to the nucleoli of infected cells
39. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
40. Nuclear domain 10, the site of DNA virus transcription and replication
41. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (1CP0)
42. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS
43. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
44. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth
45. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription
46. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function
47. A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals
48. Herpes simplex virus ICP0 mutants are hypersensitive to interferon
49. A herpesvirus ribosome-associated, RNA-binding protein confers a growth advantage upon mutants deficient in a GADD34-related function
50. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation
51. The BgIII-N fragment of herpes simplex virus type 2 contains a region responsible for resistance to antiviral effects of interferon
52. Infected cell protein 22 of herpes simplex virus 1 regulates the expression of virion host shutoff gene U(L)41
53. Mechanism for discrimination between viral and host mRNA in interferon-treated cells
54. The US 9, 10, 11, and 12 genes of herpes simplex virus type 1 are of no importance for its neurovirulence and latency in mice
55. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells
56. Production of host shutoff-defective mutants of herpes simplex virus type 1 by inactivation of the UL13 gene
57. Expression of mutant eukaryotic initiation factor 2 alpha subunit (eIF-2α) reduces inhibition of guanine nucleotide exchange activity of eIF-2B mediated by eIF-2α phosphorylation
58. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
59. Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides
60. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis
61. The herpes simplex virus Us11 open reading frame encodes a sequence-specific RNA-binding protein
62. The herpes simplex virus 1 RNA binding protein US11 is a virion component and associates with ribosomal 60S subunits
63. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture
64. Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs
65. How cells respond to interferons
66. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110
67. The virion host shutoff function of herpes simplex virus type 1 plays a role in corneal invasion and functions independently of the cell cycle
68. Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis
69. Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon alpha/beta
70. Identification of an African swine fever virus gene with similarity to a myeloid differentiation primary response gene and a neurovirulence-associated gene of herpes simplex virus
71. The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection
72. The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: A new face of death?
73. HSV.com: Maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense
74. Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells
75. Mechanism of interferon action: Characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase
76. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled
77. Postexposure vaccination with a virion host shutoff defective mutant reduces UV-B radiation-induced ocular herpes simplex virus shedding in mice
78. Classical herpes latency revisited
79. PKR; a sentinel kinase for cellular stress
80. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth
81. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways